Intuitive Surgical (ISRG) is presented as a dominant company with a near-monopoly in robotic surgery, a strong recurring revenue model, and significant growth potential, making it a compelling investment despite its high valuation.
Source Post
Deep Dive: Why Intuitive Surgical Is the Most Defensive Tech Stock (ISRG)
Fundamental Deep DiveMar 15, 2026
This deep dive analyzes Intuitive Surgical (ISRG), a company that has established a near-monopoly in soft tissue robotic surgery. The discussion covers its innovative Da Vinci surgical system, its recurring revenue business model based on disposable instruments, and its growth potential through the Ion bronchoscopy platform and international expansion. Despite a high valuation, the company's strong moat, financial health, and technological advancements like the Da Vinci 5 suggest continued dominance.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
ISRG
buy opened Mar 15, 2026
-14.80%